Follow the U S Physical Therapy INC /nv stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, U S Physical Therapy INC /nv has recorded 160 public disclosures. Market capitalisation: €1.1bn. The latest transaction was filed on 22 June 2026 (Retenue fiscale). Among the most active insiders: REEVE GRAHAM D.. All data is openly available.
Analysts rate U S Physical Therapy INC /nv Buy (bullish), based on 6 analysts. Average price target: US$93.67.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 160 declarations
U.S. Physical Therapy, Inc. (NYSE, NYSE Texas: USPH) is a U.S.-based healthcare services company focused on outpatient rehabilitation and industrial injury prevention. Headquartered in Houston, Texas, United States, the company was founded in 1990 and has grown through a partnership-oriented model that combines owned clinics with locally managed operating relationships. Today, USPH operates a broad national network of outpatient physical therapy clinics across numerous U.S. states, giving it meaningful geographic diversification and exposure to a large, fragmented market. USPH’s business is organized into two reportable segments. The core outpatient physical therapy segment provides preventive and post-operative care, treatment for orthopedic and sports-related injuries, rehabilitation for injured workers, and therapy for certain neurologic conditions. Its industrial injury prevention segment serves employer clients on site, offering injury-prevention programs, rehabilitation support, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. This dual-platform structure is strategically important: it broadens revenue streams, deepens relationships with employers and healthcare networks, and gives the company exposure to both patient-driven and B2B healthcare demand. From a competitive standpoint, USPH holds a solid position in a highly fragmented outpatient therapy industry where many local practices remain independent. Scale matters in this sector, and USPH has long used acquisitions as a key growth lever. Recent company announcements show that this strategy remains active: in 2025 and 2026, USPH completed and announced several acquisitions of multi-clinic physical therapy practices and an industrial injury prevention business, while also expanding through strategic alliances with major hospital systems. That pattern suggests a continued emphasis on disciplined consolidation, expanding clinical reach, and strengthening referral relationships. For investors, USPH presents a relatively resilient healthcare services profile supported by recurring rehabilitation demand, employer-focused occupational health services, and a proven acquisition playbook. The company’s recent disclosures also indicate ongoing investor communications through earnings releases and conference presentations, underscoring management’s focus on execution and capital allocation. In short, U.S. Physical Therapy is a niche but sizeable U.S. healthcare operator listed on the NYSE, with a hybrid model that combines outpatient care delivery and industrial injury prevention services, and with continued room for growth through selective acquisitions and network expansion.